NCT00051259已完成3 期
A Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 420
- 试验地点
- 24
- 主要终点
- Percentage of subjects with orgasm dysfunction. Change in HAMD-17 total score.
研究概览
简要总结
The purpose of this trial is to study the effects of two depression medications on sexual functioning.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary diagnosis of Major Depressive Disorder (MDD) with current duration lasting 12 weeks but no greater than 2 years.
- •Subjects must engage in sexual activity that leads to orgasm at least once every two weeks.
- •Subject must have normal orgasmic function and be willing to discuss with investigator.
排除标准
- •Subjects that have arousal or orgasm dysfunction.
- •Has previously failed to respond to two adequate trials of antidepressants in past 2 years.
- •Subject has other unstable medical disorders.
- •Subject has a positive urine test for illicit drug use at screening.
结局指标
主要结局
Percentage of subjects with orgasm dysfunction. Change in HAMD-17 total score.
次要结局
- Percent of subjects in remission, HAMD-17. Changes in Sexual Functioning Questionnaire. Percent of responders, HAMD-17 CGI-I and CGI-S.
研究者
研究点 (24)
Loading locations...
相似试验
已完成
3 期
Effects Of Antidepressants On Sexual Functioning In AdultsMajor Depressive Disorder (MDD)NCT00051272GlaxoSmithKline425
已完成
2 期
Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced LibidoLibidoNCT00566384Bayer100
已完成
4 期
Sexual Functioning Study With AntidepressantsDepressive Disorder, MajorMajor Depressive Disorder (MDD)NCT00316160GlaxoSmithKline347
已完成
3 期
Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive DisorderMajor Depressive DisorderNCT00863798Wyeth is now a wholly owned subsidiary of Pfizer682
已完成
3 期
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive DisorderMajor Depressive DisorderNCT00798707Pfizer709